Comparação da evolução das lesões de leishmaniose cutânea após tratamento com antimoniato de meglumina (5 ou 20 mg Sb5+
Gonçalves, Julia Costa de Faria.
Tesis en Portugués | ARCA | ID: arc-53321
Documentos relacionados
Alterações eletrocardiográficas em pacientes com Leishmaniose Tegumentar Americana tratados com antimoniato de meglumina: revisão integrativa
Long-term follow-up of a case of feline leishmaniosis treated with a combination of allopurinol and meglumine antimoniate.
Quantum Dynamics and Bi Metal Force Field Parameterization Yielding Significant Antileishmanial Targets.
Topical application of ozonated sunflower oil accelerates the healing of lesions of cutaneous leishmaniasis in mice under meglumine antimoniate treatment.
Assessing the effect of antimony pressure on trypanothione reductase activity in Leishmania (Viannia) braziliensis.
Efficacy of Meglumine Antimoniate in a Low Polymerization State Orally Administered in a Murine Model of Visceral Leishmaniasis.
[Determination of Antimony Resistance Mechanism of Leishmania tropica Causing Cutaneous Leishmaniasis in Turkey].
Owners' experiences of administering meglumine antimoniate injections to dogs with leishmaniosis: An online questionnaire study.
A Randomized, Controlled, Noninferiority, Multicenter Trial of Systemic vs Intralesional Treatment With Meglumine Antimoniate for Cutaneous Leishmaniasis in Brazil.
Localized leishmaniasis treated with intralesional meglumine antimoniate.